IT1274241B - Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono - Google Patents
Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengonoInfo
- Publication number
- IT1274241B IT1274241B ITMI932540A ITMI932540A IT1274241B IT 1274241 B IT1274241 B IT 1274241B IT MI932540 A ITMI932540 A IT MI932540A IT MI932540 A ITMI932540 A IT MI932540A IT 1274241 B IT1274241 B IT 1274241B
- Authority
- IT
- Italy
- Prior art keywords
- pharmaceutical compositions
- therapeutic agent
- compositions containing
- polymer matrix
- flavor characteristics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6943—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a pill, a tablet, a lozenge or a capsule
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI932540A IT1274241B (it) | 1993-12-03 | 1993-12-03 | Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono |
| PCT/EP1994/003903 WO1995015155A1 (en) | 1993-12-03 | 1994-11-24 | Taste masked composition containing a drug/polymer complex |
| AU12198/95A AU693144B2 (en) | 1993-12-03 | 1994-11-24 | Taste masked composition containing a drug/polymer complex |
| CN94194885A CN1145586A (zh) | 1993-12-03 | 1994-11-24 | 含药物/聚合物复合物的味掩蔽组合物 |
| JP7515376A JPH09505818A (ja) | 1993-12-03 | 1994-11-24 | 薬／ポリマー複合体含有の風味をマスクした組成物 |
| EP95903281A EP0804168A1 (en) | 1993-12-03 | 1994-11-24 | Taste masked composition containing a drug/polymer complex |
| NZ277238A NZ277238A (en) | 1993-12-03 | 1994-11-24 | Taste masked composition containing paroxetine complexed with a polymer |
| CA002177721A CA2177721A1 (en) | 1993-12-03 | 1994-11-24 | Taste masked composition containing a drug/polymer complex |
| ZA949567A ZA949567B (en) | 1993-12-03 | 1994-12-01 | Chewable taste masked complexes containing pharmaceuticals |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI932540A IT1274241B (it) | 1993-12-03 | 1993-12-03 | Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITMI932540A0 ITMI932540A0 (it) | 1993-12-03 |
| ITMI932540A1 ITMI932540A1 (it) | 1995-06-03 |
| IT1274241B true IT1274241B (it) | 1997-07-15 |
Family
ID=11367288
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITMI932540A IT1274241B (it) | 1993-12-03 | 1993-12-03 | Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0804168A1 (it) |
| JP (1) | JPH09505818A (it) |
| CN (1) | CN1145586A (it) |
| AU (1) | AU693144B2 (it) |
| CA (1) | CA2177721A1 (it) |
| IT (1) | IT1274241B (it) |
| NZ (1) | NZ277238A (it) |
| WO (1) | WO1995015155A1 (it) |
| ZA (1) | ZA949567B (it) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU748804B2 (en) * | 1995-07-20 | 2002-06-13 | Smithkline Beecham Plc | Paroxetine controlled release compositions |
| GB9514842D0 (en) * | 1995-07-20 | 1995-09-20 | Smithkline Beecham Plc | Novel formulation |
| US6548084B2 (en) * | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
| CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
| US5965555A (en) * | 1996-06-07 | 1999-10-12 | Hoechst Aktiengesellschaft | Xanthine compounds having terminally animated alkynol side chains |
| DE19631084A1 (de) * | 1996-08-01 | 1998-02-05 | Basf Ag | Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut |
| US6638948B1 (en) | 1996-09-09 | 2003-10-28 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
| EP1078925A1 (en) | 1997-06-10 | 2001-02-28 | Synthon B.V. | 4-Phenylpiperidine compounds |
| US5955475A (en) * | 1997-06-30 | 1999-09-21 | Endo Pharmaceuticals Inc. | Process for manufacturing paroxetine solid dispersions |
| PL197989B1 (pl) * | 1997-12-19 | 2008-05-30 | Smithkline Beecham Corp | Sposób wytwarzania szybko rozpraszających się tabletek do podawania doustnego, szybko rozpraszający się preparat farmaceutyczny w postaci tabletek i szybko rozpraszająca się, farmaceutycznie dopuszczalna, tabletka do podawania doustnego |
| IT1298732B1 (it) * | 1998-03-13 | 2000-02-02 | Recordati Chem Pharm | Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione |
| CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
| EP1161241B1 (de) | 1999-03-12 | 2005-12-07 | Aesica Pharmaceuticals Ltd. | Stabile pharmazeutische anwendungsform für paroxetin-anhydrat |
| JP2005501066A (ja) * | 2001-08-09 | 2005-01-13 | スミスクライン ビーチャム パブリック リミテッド カンパニー | パロキセチンおよび医薬上許容されるグリチルリチン酸塩を含む組成物 |
| GB0119467D0 (en) * | 2001-08-09 | 2001-10-03 | Smithkline Beecham Plc | Novel compound |
| EP2802311B1 (en) * | 2011-10-25 | 2018-12-12 | Expermed S.A. | Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU589991B2 (en) * | 1985-08-26 | 1989-10-26 | G.D. Searle & Co. | Taste masking compositions |
-
1993
- 1993-12-03 IT ITMI932540A patent/IT1274241B/it active IP Right Grant
-
1994
- 1994-11-24 CN CN94194885A patent/CN1145586A/zh active Pending
- 1994-11-24 NZ NZ277238A patent/NZ277238A/en unknown
- 1994-11-24 WO PCT/EP1994/003903 patent/WO1995015155A1/en not_active Application Discontinuation
- 1994-11-24 EP EP95903281A patent/EP0804168A1/en not_active Withdrawn
- 1994-11-24 AU AU12198/95A patent/AU693144B2/en not_active Ceased
- 1994-11-24 JP JP7515376A patent/JPH09505818A/ja active Pending
- 1994-11-24 CA CA002177721A patent/CA2177721A1/en not_active Abandoned
- 1994-12-01 ZA ZA949567A patent/ZA949567B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA949567B (en) | 1995-10-10 |
| ITMI932540A1 (it) | 1995-06-03 |
| JPH09505818A (ja) | 1997-06-10 |
| CN1145586A (zh) | 1997-03-19 |
| AU693144B2 (en) | 1998-06-25 |
| NZ277238A (en) | 1998-04-27 |
| AU1219895A (en) | 1995-06-19 |
| ITMI932540A0 (it) | 1993-12-03 |
| WO1995015155A1 (en) | 1995-06-08 |
| EP0804168A1 (en) | 1997-11-05 |
| CA2177721A1 (en) | 1995-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1274241B (it) | Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono | |
| NL300212I1 (nl) | ASP-B28 insulinekristallen. | |
| BR1100824A (pt) | Composto e composição farmacêutica | |
| CA2180554A1 (en) | Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds | |
| FI954767A (fi) | Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus | |
| FR2753376B1 (fr) | Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques | |
| ITMI931325A1 (it) | Composizione farmaceutica ad attivita' analgesica | |
| BR9509688A (pt) | Composto e composição farmacêutica | |
| IL117599A0 (en) | Pharmaceutical matrix pellets tablets and composition for the preparation thereof | |
| EP0489102A4 (en) | Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same | |
| IT1274655B (it) | Composizioni farmaceutiche contenenti un agente antiinfiammatorio e un agente antimicrobico | |
| NO20013117D0 (no) | Kosmetisk preparat av spray-type og matriks anvendt i preparatet for dermal administrering | |
| BR8904606A (pt) | Composicao,produto endurecivel e aplicacao | |
| ITMI911147A0 (it) | Composto ad attivita' terapeutica,sua preparazione e composizioni farmaceutiche che lo contengono | |
| ITMI932543A1 (it) | Composizione farmaceutica | |
| IL110833A0 (en) | Naphthoxazines, their preparation and pharmaceutical compositions containing them | |
| NO306613B1 (no) | Oligomer og farmasöytisk preparat omfattende denne | |
| SI0804165T1 (en) | Solid medicament form with active agent distributed in polymer material | |
| IT8820572A0 (it) | Agente antitussivo e mucoregolatore, sua preparazione e composizioni farmaceutiche. | |
| BR1100293A (pt) | Composto e composição farmacêutica | |
| BR1100809A (pt) | Composto e composição farmacêutica | |
| ITMI921741A1 (it) | Composizione farmaceutica o dietetica ad elevata attivita' antiossidante nelle patologie cardiovascolari e/o epatiche | |
| ITMI920445A1 (it) | Composizione farmaceutica o dietetica ad elevata attivita' antiossidante nelle patologie cardiovascolari e/o epatiche | |
| ITMI930453A1 (it) | Composizione farmaceutica avente attivita' antiasmatica | |
| BR1100691A (pt) | Composto, e, composição farmacêutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted | ||
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19981231 |